PapersPMID:27324590
Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.
- 01 · finding
- 1
- 02 · compound
- 1
- 03 · endpoint
- 1
- 04 · null
- 0
What it reported
How to read these marksWhat moved
1 finding
(-)-epigallocatechin 3-gallate — decreases LDL cholesterol
Evidence strength: very limited.Findingreplicated ×1“According to weighted mean differences for changes from baseline with 95% confidence intervals (CI), 107-856 mg/d of EGCG for 4 to 14 weeks reduced LDL-C by -9.29 mg/dl (95% CI, -12.27 to -6.31).”
Quoted verbatim from Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.. - Study
- meta-analysis
- Dose
- 107-856 mg/d for 4 to 14 weeks
- Population
- healthy individuals, pooled across 17 randomized controlled trials of EGCG for 4 to 14 weeks
Effect -9.29 mean difference, 95% CI -12.27 to -6.31
Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.2016PMID:2732459010.1080/09637486.2016.1196655Permalink
Study record
Read under: (-)-epigallocatechin 3-gallate
- Design
- meta-analysis
- Species
- human
- Population
- healthy individuals, pooled across 17 randomized controlled trials
- Participants
- not recorded
- Comparator
- not stated in the paper
- Duration
- not recorded
- Endpoints
- 1
- Record
- extracted
- Readings recorded
- 2